The U.S. cannabis industry continues to expand, with over 80% of Americans now supporting some form of legalization. Recent headlines show the DEA is likely to reschedule marijuana from Schedule I to Schedule III. This move could ease tax burdens and promote medical research. Analysts project the legal U.S. cannabis market could surpass $71 billion by 2030. As more states adopt legal programs, smaller companies with growth potential are gaining attention. Therefore, marijuana penny stocks remain attractive to traders looking for high-reward opportunities. However, the sector is still volatile. Investors should combine technical analysis with sound risk management strategies. Look for price support levels, breakout setups, and volume confirmations. Also, use proper stop-loss orders to manage risk. With legalization efforts gaining momentum, short-term spikes are likely. Thus, traders should stay alert this week. Momentum, news catalysts, and chart setups will help identify top entries.

Many catalysts continue to build toward full cannabis legalization in the U.S. The SAFE Banking Act could pass by 2025, providing financial services access to cannabis businesses. Additionally, more states are preparing for ballot initiatives in 2026 and 2028. These changes will likely increase investor interest in cannabis stocks, especially low-priced ones. As the market reacts to legalization news, marijuana penny stocks often show fast moves.

Marijuana Stocks with Rebound Potential

Because of their affordability, these stocks allow exposure with limited capital. However, their volatility requires extra caution. Traders must use chart patterns, moving averages, and volume indicators. Also, focus on entries near support with clear upside targets. Watching for confirmation and avoiding emotional decisions is key. Moreover, stay updated with news developments and legislative updates. As always, use a trade plan with risk parameters in place. This week, several penny stocks are positioned to benefit from current momentum. Let’s review the most promising names now.

As the U.S. cannabis industry gains momentum, investors are eyeing select stocks with growth potential. Federal rescheduling is expected soon, which could reduce operators’ tax burdens and attract institutional capital. The SAFE Banking Act also remains on the table. Meanwhile, consumer demand continues rising in both medical and recreational markets. In this environment, several marijuana companies are positioned for strong performance. The following are three top marijuana stocks to watch in May 2025.

[Read More] Marijuana Market Set to Surge by 2030— Here Are This Week’s Top U.S. Stock Picks

Top Marijuana Stocks to Watch in May 2025

1. Verano Holdings Corp. (OTC: VRNOF)
2. Cansortium Inc. (OTC: CMTNF)
3. Ayr Wellness Inc. (OTC: AYRWF)

Verano Holdings Corp. (VRNOF)

Verano Holdings is a major U.S. multi-state operator with a large retail presence. The company operates over 150 dispensaries nationwide. Florida is its largest market, where it runs more than 80 stores. Verano also has locations in Illinois, New Jersey, and Arizona. The company sells both medical and recreational cannabis under brands like Zen Leaf and MÜV. Its footprint spans 13 states, giving it broad market exposure. This helps Verano adapt to new regulations and consumer demand. The company continues expanding through strategic acquisitions and organic growth. Management has focused on building scale and efficiency across regions. Verano has earned a reputation for premium products and consistent operations. As the industry matures, Verano aims to strengthen its national market share. Its broad retail network provides strong positioning for future U.S. legalization. In May 2025, Verano remains one of the most watched names in cannabis.

Verano’s latest financial results show mixed performance due to market pricing pressure. Quarterly revenue reached $210 million, slightly down from the previous year. Gross profit stood at $100 million, reflecting tighter margins. The company reported an adjusted EBITDA of $54 million. This represented 26% of total revenue, showing stable operating performance. However, the net loss was $12 million, reflecting ongoing challenges. Despite that, Verano produced positive operating cash flow of $2 million. Capital spending totaled $14 million, aimed at upgrading retail facilities. The company remains focused on cutting costs while preserving long-term growth. Verano continues to streamline operations in maturing markets. The balance sheet remains stable, with manageable debt levels. Management expects improved pricing conditions in the second half of 2025. Investors will be watching for signs of margin recovery and stronger cash flow. Overall, Verano remains a solid operator with long-term potential.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

Cansortium Inc. (CMTNF)

Cansortium Inc. is a U.S.-based cannabis company operating under the Fluent brand. Its largest presence is in Florida, with more than 20 dispensaries. The company is vertically integrated, handling cultivation, processing, and retail. Cansortium serves medical cannabis patients with a wide range of products. These include flower, edibles, oils, and capsules. The company is expanding its geographic footprint through strategic partnerships. It has recently entered new markets to diversify revenue streams. Cansortium has focused on building efficiency at its Florida operations. This includes upgrading cultivation facilities to increase output. The company also continues investing in product innovation. Its dispensaries emphasize education and patient experience. Cansortium’s small-cap status makes it attractive to penny stock investors. It offers exposure to Florida’s large and growing medical market. As regulatory momentum builds, this operator could see increased upside. Cansortium remains a stock to watch closely in May 2025.

Financially, Cansortium is focused on improving profitability. The company generated annual revenue of approximately $104 million. This marks steady growth from the previous year. However, earnings remain under pressure with a negative EPS. The company is actively reducing operating costs and increasing production efficiency. Management is working to expand margins and improve free cash flow. Debt levels are moderate, with upcoming maturities being refinanced. Capital expenditures remain conservative to preserve cash reserves. Cansortium is prioritizing core markets while evaluating potential acquisitions. The company continues investing in cultivation infrastructure. It also maintains adequate liquidity for operational needs. Analysts are watching closely for signs of earnings improvement. Strong sales performance in Florida could support positive surprises. As pricing conditions stabilize, Cansortium may return to profitability. Investors should also monitor its expansion into new states. Overall, the company is progressing toward a stronger financial footing in 2025.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Ayr Wellness Inc. (AYRWF)

Ayr Wellness is a vertically integrated cannabis company with operations in several U.S. states. It runs more than 90 licensed dispensaries. Florida is its largest market, followed by Pennsylvania and Massachusetts. Ayr also operates in New Jersey, Nevada, and Illinois. The company continues expanding into Ohio, with several new stores planned. Its brand portfolio includes retail and wellness-based cannabis products. Ayr targets both medical and adult-use customers through tailored offerings. The company focuses on high-quality cultivation and sustainable practices. It invests in staff training, compliance, and patient education. Ayr’s strategic footprint allows access to large and emerging markets. This supports long-term growth as legalization efforts advance. The company has worked to streamline operations and improve efficiency. It aims to be a low-cost producer with premium retail service. Ayr’s footprint, product variety, and operating scale make it a top stock to watch.

Ayr Wellness has taken decisive steps to improve its balance sheet. The company ended 2024 with over $35 million in cash. Operating cash flow reached $9.6 million in the final quarter. Capital expenditures declined to $17.7 million for the year. This helped preserve liquidity and fund core operations. Ayr has focused on cutting debt, reducing interest expenses, and extending maturities. Nearly $400 million in debt was restructured with new terms. Additionally, the company raised new funds through senior note issuance. These moves reduced financial pressure and improved the outlook. Ayr is also focused on revenue growth and margin expansion. New product launches and store openings are expected in 2025. Gross margins remain under pressure but are gradually improving. Ayr’s financial discipline and cost control are key strengths. Investors will be watching for continued revenue growth and stronger profitability. With an improving financial base, Ayr remains well-positioned in the cannabis space.

U.S. Weed Stocks to Track Before the Next Breakout

In conclusion, these three companies—Verano, Cansortium, and Ayr Wellness—stand out for their operational scale and strategic expansion. Each has faced market challenges but continues to position itself for long-term growth. As federal reform efforts progress, these stocks may offer substantial upside. Traders and investors should continue tracking performance, technical levels, and news-driven catalysts in May 2025.

The post Top U.S. Marijuana Stocks to Add to Your Watchlist Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stock investors are working to stay poised during this ongoing volatile downtrend. Now even though the public sector is in a downtrend has not stopped industry progression as companies continue to generate large amounts of revenue. The cannabis industry has seen significant advancements in 2025. Much of which has been marked by increased and improved legalization. In addition to more companies working with technological innovations, and an expanding health and wellness market with cannabis as the focus.

More states and countries are recognizing the potential economic benefits of cannabis. With this, an increase in the growing number of regions have legalized both medicinal and recreational use. This expanded legal framework has attracted major investors which is why the frustrations are at an all-time high with the public sector. To enhance the trading performance of cannabis stocks, several scenarios could be beneficial. Firstly, greater transparency and standardization in product labeling can build consumer trust and confidence in cannabis products.

Additionally, enhancing regulatory clarity can attract institutional investors who have previously avoided the sector due to legal uncertainties. All of the above play a factor in trusting the market regardless of what is occurring. It is a classic risk vs reward with how things are in the sector. Nevertheless, there is still optimistic speculation for some shareholders and investors. Below are several marijuana stocks to watch and learn about over the Memorial Day break.

Marijuana Stocks To Know About In 2025

1. Leafly Holdings, Inc. (OTC:LFLY)
2. WM Technology, Inc. (NASDAQ:MAPS)
3. High Tide Inc. (NASDAQ:HITI)

Leafly Holdings, Inc.

Leafly Holdings, Inc. operates as an online cannabis discovery marketplace and resource in the United States and internationally. It has been a bit of time since the company has released any current updates.

However, on January 16th, the company held a receipt of notice of delisting from the Nasdaq and transition to OTC market.

WM Technology, Inc.

WM Technology, Inc., an online cannabis marketplace, provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. On May 8th the company reported its Q1 2025 results.

First Quarter 2025 Financial Highlights

• Revenues for the first quarter ended March 31, 2025 was $44.6 million as compared to $44.4 million in the prior year period.
• Average monthly paying clients(1) of 5,179 increased from 4,937 in the prior year period, largely due to new client acquisitions across certain markets.
• Net income increased to $2.5 million from $2.0 million in the prior year period.
• Adjusted EBITDA(3) increased to $10.1 million from $9.6 million in the prior year period.

[Read More] Top Marijuana Stocks In A Volatile Market

Words From The Company

“Our first quarter results reflect focused execution in what remains a challenging environment for the cannabis industry,” said Doug Francis, CEO of WM Technology. ”

[Read More] 2025’s Best Cannabis REITs for Building Wealth Over Time

High Tide Inc.

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. It operates through Bricks and Mortar Operations; and E-commerce Operations segments.

In recent news the company announced the opening of new Canna Cabana store in Cornwall, Ontario. This opening brings High Tide’s total store count to 197 Canna Cabana branded locations across Canada, and 81 in the province of Ontario.

The post 3 Marijuana Stocks That Could Be The Long Term Money Maker appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.

But this has yet to help how marijuana stocks perform. There has been a volatile downturn for some time, and even with the progress of business pot stocks won’t move up. Now, with this success for legal operators around the globe, it gives hope for those who want to enter the sector. For instance, watching how an MSO powerhouse like Trulieve can make all this money but trade poorly. Yet even with the market down, the success outside of the public sector keeps positive speculation going. Many feel this is the time to find top marijuana stocks to buy.

People feel the future is where the gains will be made. A classic buy-and-hold long-term strategy is what many are feeling will be the better option. When federal reform matters are met, it has the potential to bring the trading up in a major way. Many are keeping watch for any volatile pops o trading to take profits until the big payday occurs. Below are several marijuana stocks to watch today.

Marijuana Stocks For Investors Who Like Legal Cannabis 2025

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Canopy Growth Corporation (NASDAQ:CGC)
3. Cronos Group Inc.(NASDAQ:CRON)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. 

The company recently announced that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours. This product is a new line of cannabis beverages and gummies that redefine the sour experience.

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Recently, the company announced it will release its Q1 2025 financial results on May 30th. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Judy Hong, CFO.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. Back on May 8th, the company reported its Q1 2025 earnings.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

2025 Highlights And Key Mentions

• Net revenue of $32.3 million in Q1 2025 increased by $7.0 million from Q1 2024.
• Gross profit of $13.7 million in Q1 2025 increased by $9.3 million from Q1 2024.
• Adjusted Gross Profit of $14.3 million in Q1 2025 increased by $9.8 million from Q1 2024.
• Net income of $7.7 million in Q1 2025 increased by $10.2 million from Q1 2024.

The post Top Marijuana Stocks In A Volatile Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry is still showing signs of profitability, with companies reporting strong 2025 earnings. Much of the legal market, even with its uphill battle, is standing strong. This shows people that even though it is not federally legal, there is still an abundance of success at the state level. As well as other legal markets in various global regions, all of which play a big role as a whole for cannabis.

Yet much of this success has not exactly translated into better trading for public cannabis companies. The bulk of marijuana stocks are still facing a massive downtrend. However, there is hope for the future and daily bounces that many investors want to take gains as they come. Now, due to how unpredictable the sector can be, there is no way to know when a monumental bounce will happen.

So the idea is that as things progress for legal cannabis down the line, that will help fuel better trading for cannabis stocks. Many feel that once federal reform comes into play, it will ease volatile trading. Most shareholders do not feel safe to make trades or invest as they would with it in place. Cannabis should be seen as a legitimate industry like any other, especially with the large tax revenue legal states are making. Hopefully, this will soon carry over to the public sector to help some of these top marijuana stocks to watch today.

Marijuana Stocks For Long-Term Investing

1. Trulieve Cannabis Corp. (OTC:TCNNF)
2. GrowGeneration Corp. (NASDAQ:GRWG)
3. Curaleaf Holdings, Inc. (OTC:CURLF)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. 

In more recent news the company announced the opening of a new Trulieve-branded dispensary in Lorain, Ohio. Harvest Grows LLC will operate the dispensary under the Trulieve brand through a licensing agreement with the Company.

Words From The Company

“We are thrilled to open this new dispensary under our licensing agreement with Trulieve,” said Harvest’s Chief Executive Officer, Mark Eiland. “We are proud to be associated with the Trulieve brand and look forward to serving customers at this new location.”

[Read More] These 2 Marijuana Stocks Are Making Money Outside Of The Stock Market

GrowGeneration Corp.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It operates through two segments, Cultivation and Gardening, and Storage Solutions. Recently, the company announced the launch of MMI Storage Solutions’ new mobile package and luggage solution.

It was designed exclusively for the Waldorf Astoria, one of the world’s most iconic luxury hotel brands. This custom-engineered system will elevate the Waldorf guest experience. The new setup will be done by providing hotel staff with an elegant, efficient, and secure way to handle guest luggage.

[Read More] 3 Marijuana Stocks For Cannabis Real Estate Investors

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. On May 16th the company released news regarding the opening of a new dispensary in Lima Ohio.

The store expands Curaleaf’s footprint in the Buckeye State to three stores, bringing the Company’s nationwide retail footprint to 152 locations. Curaleaf Lima will increase convenient access to high-quality cannabis for both medical patients and adult-use customers across northwest Ohio.

The post Marijuana Stocks To Buy Today And Trade Tomorrow? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stock investors are at the mercy of not just the market but the politics of the entire industry. What this means is that with no federal reform and a lack of regulatory matters met the public sector for cannabis stocks is at all-time lows. Right now, if you are interested in cannabis, you can buy marijuana stocks to buy at lower-than-normal share prices.

Now, many are waiting patiently, and many have grown in frustration. For instance, how can businesses be booming for legal operators, and none of that success has led to better trading? At one point in time, when legal operators did well, so did the market. But that is not the case, and many have been taking profits as they can when they can catch a volatile pop in trading. Now for some time, any upward trading has been short-lived making it nearly impossible to see any gains.

Yet, with how well the cannabis industry as a whole is doing, future gains keep people optimistic. Right now is more of and buy-and-hold time, where shares are so low that this strategy could be profitable. It’s all about patience, strategizing, and choosing the right cannabis stocks to invest in. Below are a few marijuana stocks to watch that could be among the few to see momentum increase.

Marijuana Stocks To Keep On Your Radar

1. Greenlane Holdings, Inc. (NASDAQ:GNLN)
2. Jushi Holdings Inc. (OTC:JUSH)

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. engages in the development and distribution of cannabis accessories, vape devices, and lifestyle products in the United States, Canada, Europe, and Latin America. It has been some time since the company has reported any new updates.

But on March 25th, the company announced it would join the Mainstem B2B procurement marketplace platform. MainStem offers an end-to-end, enterprise-level supply chain solution designed to streamline procurement for the legal cannabis industry.

[Read More] These Cannabis Stocks Could Pay Off Big In The Future

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. On May 8th, the company reported its first quarter of 2025.

[Read More] 3 Marijuana Stocks For Cannabis Real Estate Investors

First Quarter 2025 Financial Highlights

• Total revenue of $63.8 million
• Gross profit and gross profit margin of $25.8 million and 40.4%, respectively
• Net loss of $17.0 million
• Adjusted EBITDA1 and Adjusted EBITDA margin1 of $9.8 million and 15.4%, respectively
• Cash, cash equivalents, and restricted cash of $27.9 million as of quarter end
• Net cash flows provided by operations of $7.5 million

The post 2 Marijuana Stocks That Could Make You Money In 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The way the cannabis industry is booming, you would think this success would help marijuana stocks. However, this has not been the case, but that has not stopped the industry from thriving. Right now is a unique time for legal cannabis and the companies in the industry. For the companies that are publicly traded, they are truly feeling the impact of what’s occurring.

Now, this isn’t to say things can not change for the better. But at this time, that is not the case. For the more optimistic investors, they see cannabis as buy now, sell later. Especially with all the success and revenue being made. It is one of those things where patience is key, and you need to be willing to take the risk. Almost all of America has some form of legal cannabis market. Each market, for better or worse, is making cash flow, and if money is being made, then there is opportunity on the horizon.

Even with a massive downtrend, once things change from a federal and regulatory standpoint point marijuana stocks could rapidly shoot up. Currently, this is a time to observe and strategize as the industry further expands. The 2 marijuana stocks to watch that are mentioned below are potential companies that may hold the potential to yield profits in 2025.

Top Marijuana Stocks In Down Trend

1. Planet 13 Holdings Inc. (OTC:PLNH)
2. Verano Holdings Corp. (OTC:VRNOF)

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. During the months of April and May, the company has made 2 new announcements.

On April 29th, the company announced the opening of a new Florida Dispensary. The grand opening of Planet 13 Edgewater will be on May 31, 2025, the Company’s 33rd dispensary in Florida and 37th nationwide. However, on May 7th announced today that it plans to release its financial results for the first quarter ended March 31st, 2025, on May 14th, 2025, after the market.

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States.  The company like others in the space have recently reported Q1 2025 earnings.

First Quarter 2025 Financial Highlights

• Revenues, net of discounts, of $210 million, a decrease of 5% year-over-year, and a decrease of 4% versus the prior quarter.
• Gross profit of $100 million or 47% of revenue.
• SG&A expenses of $85 million or 40% of revenue.
• Net Loss of $(12) million or (5)% of revenue.
• Adjusted EBITDA1 of $54 million or 26% of revenue.

Words From The CEO

“I am very pleased with the progress we made during the first quarter executing our strategic priorities leveraging innovation, automation and differentiation, while driving efficiencies across the business,” said George Archos, Verano founder, chairman and Chief Executive Officer.”

The post These 2 Marijuana Stocks Are Making Money Outside Of The Stock Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Is it safe to invest in marijuana stocks with the entire sector trading at all-time lows? If the legal market is profitable and companies are performing well, why are the top marijuana stocks not trading? These are just some of the questions that plague investors and shareholders. The answer is not so simple, which can make things a bit more complex to understand. Although legal cannabis as a business is thriving and growing in all areas, this has not translated to the public sector so well.

Some feel that it’s like walking on a razor blade without better laws in place on the federal level. There is still much fear of what could happen without federal reform or even SAFE Banking in an industry generating billions of dollars. Legal cannabis has come such a long way that it is just a matter of when. But without it in place, it has hurt the confidence of many investors.

Now, what other areas of cannabis investing could be good are companies that do not solely deal directly with the plant. The ancillary side of cannabis could be a potential haven for better profits at this time. With all things, nothing is a guarantee, and with proper planning, you could see a return. The marijuana stocks to watch below are companies that are in cannabis but do not rely only on the industry to be successful.

Top Ancillary Marijuana Stocks For You

1. Innovative Industrial Properties, Inc. (NYSE:IIPR)
2. NewLake Capital Partners, Inc. (OTC:NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership, and management of specialized properties.

Particularly properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Recently, the company reported its Q1 2025 earnings.

Highlights Key Mentions

• Innovative Industrial Properties Inc reported total revenues of $71.7 million and adjusted funds from operations (AFFO) of $55.3 million for the first quarter of 2025.
• The company ended the period with over $220 million in total liquidity, showcasing a strong financial position.
• IIPR successfully acquired a $7.8 million industrial facility in Maryland and executed two new leases totaling 211,000 square feet.

NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally managed real estate investment trust that provides real estate capital to state-licensed cannabis operators.

This is done through a sale-leaseback transaction, third-party purchases, and funding for build-to-suit projects. On May 7th, the company reported its 2025 first quarter results.

First Quarter 2025 Financial and Operational Highlights

• Revenue totaled $13.2 million.
• Net income attributable to common stockholders totaled $6.3 million.
• Funds From Operations (“FFO”)(2) totaled $10.3 million.
• Adjusted Funds From Operations (“AFFO”)(2) totaled $10.7 million.
• Declared a first quarter dividend of $0.43 per common share, equivalent to an annualized dividend of $1.72 per common share.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial mortgage real estate investment trust in the United States.

The company engages in originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. In more recent news, the company has reported its Q1 2025 financial results.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

First Quarter 2025 Financial Highlights

• Net interest income of approximately $13.0 million as of March 31, 2025.
• Total expenses of approximately $4.1 million before provision for current expected credit losses, representing a sequential decrease of approximately 28.3%.
• Net Income of approximately $10.0 million, or $0.47 per weighted average diluted common share, representing a sequential increase of 20.5% on a per share basis.

The post 3 Marijuana Stocks For Cannabis Real Estate Investors appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF),  (“Charlotte’s Web” or the “Company”), a botanical wellness innovation company, today announced results for the quarter ended March 31, 2025, reporting its first year-over-year revenue increase in more than three years, building on the sequential quarterly growth trend achieved in 2024.

“Following three sequential quarters of improvement in 2024, Q1 delivered our first year-over-year revenue growth since 2021 – validating the transformation we initiated 18 months ago,” said Bill Morachnick, Chief Executive Officer. “Our upgraded e-commerce platform is converting more visitors, and new digital storefronts on Amazon, TikTok Shop, and Faire are widening our reach. An upcoming nationwide rollout with Whole Foods Market will strengthen our retail footprint. Operationally, we commenced initial in–house gummy production and, as part of our disciplined cost agenda, we mutually concluded our promotional rights agreement with MLB and associated costs. Coupled with robust innovation – including cannabinoid isolates and our new functional mushroom gummy line – we believe these initiatives position the Company to deliver top and bottom-line growth for 2025 and beyond.”

Erika Lind, Chief Financial Officer, added, “Our reengineered cost structure is now flowing through the P&L. Building on the positive traction from the prior quarters, we are structuring for further improvements in cost efficiency and cash flow. As a part of this effort, we have concluded some high-cost promotional sports agreements, thereby eliminating sizeable future cash outlays of more than $18 million over the next three years. This supports near-term cash flow and preserves long-term cash for further investment in innovation. Combined with our transitioning to in-house manufacturing and disciplined SG&A control, we anticipate further improvements to cash flow in 2025.”

First Quarter Business Review

Expansion of Mushroom Wellness Gummy Innovations
Following the successful Q4 2024 launch of its functional mushroom gummies targeting focus, stress, and energy, Charlotte’s Web will continue expanding its botanical wellness portfolio in 2025. The Company’s strategic diversification beyond CBD is gaining market traction with mushroom wellness products now available through multiple distribution channels, including Walmart.com, Amazon.com, and the Company’s direct-to-consumer platform.

E-Commerce Growth and Omnichannel Expansion
Building on the sequential gains recorded in 2024, Charlotte’s Web’s digital channels delivered year-over-year growth in Q1 2025. Order volume growth, stabilized average order values, new subscriber increases, and lower churn rates drove meaningful digital revenue growth and underscored brand loyalty. This performance reflects the past year’s technology and go-to-market enhancements: a unified brand architecture, an expanded product portfolio, data-driven segmentation, an upgraded e-commerce stack, and improved engagement tools such as SMS outreach and an influencer network that now reaches more than one million consumers.

The Company has widened its omnichannel footprint. Walmart.com added Charlotte’s Web’s new mushroom wellness gummies during the quarter, while strategic launches on Amazon, TikTok Shop, and Faire have dramatically broadened online reach. With additional categories and channels slated for launch in the coming quarters, the Company is well-positioned to meet consumers wherever they shop, diversifying revenue streams, and capturing incremental market share through improved digital discoverability.

Whole Foods Market Retail Distribution Launch
In a significant advancement of its retail expansion, the Company achieved a major milestone finalizing an agreement with Whole Foods Market to roll out products to more than 400 store locations nationwide. As part of this partnership, three isolate topical products will be available on shelves starting June 2025. This launch marks a significant step forward in making botanical wellness solutions more accessible to health-conscious consumers seeking trusted, plant-based alternatives.

Operational Efficiencies and Cost Management
Expense reductions initiated in 2024 continued to benefit operating performance, with year-over-year operating costs down 24.2%. Strengthening operations, Charlotte’s Web began preliminary in-house commercial production of gummies in Q2 2025, supporting gross margins and speed-to-market for new products. This production shift will enable the rapid development of new gummy blends.

“With successful expansion into new product categories, improving cash flow metrics, and enhanced operational efficiencies, Charlotte’s Web has a good start to 2025,” added Mr. Morachnick. “Our disciplined execution of strategic initiatives – from platform expansion to manufacturing optimization – positions us to build on this throughout 2025 and beyond, delivering value for shareholders and continued innovation for consumers.”

DeFloria Milestone
In the first quarter, DeFloria, Inc. – a joint entity established between Charlotte’s Web and Ajna BioSciences, with British American Tobacco as lead investor – received U.S. Food and Drug Administration (FDA) clearance to initiate Phase 2 clinical trials for its botanical pharmaceutical candidate, AJA001 Oral Solution, intended to treat irritability associated with autism spectrum disorder (“ASD”). AJA001 is formulated using Charlotte’s Web proprietary full-spectrum CBD extract derived from its patented cultivars. The FDA’s acceptance of DeFloria’s IND for AJA001 marks a significant milestone. In addition, Charlotte’s Web holds manufacturing rights for commercial supply when the drug is ultimately approved by the FDA, representing a potential opportunity that could be transformative for Charlotte’s Web over time.

On June 9, 2025, Charlotte’s Web and Ajna BioSciences will host an executive panel session at the Benzinga Cannabis Capital Conference in Chicago. As part of the panel discussion, Charlotte’s Web will showcase its partnership with DeFloria and AJA001’s clinical progress and therapeutic potential. For attendance information, contact IR@defloira.bio.

First Quarter 2025 Financial Review
The following table sets forth selected financial information for the periods indicated:

Three months ended

March 31,

U.S. $ millions, except per share data

2025

2024

Revenue

$

12.3

$

12.1

Cost of goods sold

$

6.1

$

5.2

Gross profit

6.2

6.9

Selling, general and administrative expenses

11.6

15.3

Operating loss

(5.4)

(8.4)

Change in fair value of financial instruments and other

(0.1)

(1.9)

Other income (expense) , net

(0.7)

0.6

Net loss

$

(6.2)

$

(9.7)

EPS basic and diluted

$

(0.04)

$

(0.06)

Adjusted EBITDA(1)

$

(2.8)

$

(3.9)

Assets:

Cash and cash equivalents

$

19.4

Total assets

$

108.0

Liabilities:

Long-term liabilities

$

68.5

Total liabilities

$

87.0

Quarterly revenue trend:

Q1

Q2

Q3

Q4

Q1

U.S. $ millions

2024

2024

2024

2024

2025

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

$ 12.3

Consolidated net revenue for the first quarter ended March 31, 2025, was $12.3 million, a year-over-year increase of 1.1% compared to $12.1 million in the first quarter of 2024. Propelled by the continued performance of the Company’s upgraded e-commerce platform, this represents the first period of year-over-year growth reported since Q2 2021 and builds upon a consecutive quarterly growth trend established in 2024. Introduced in mid-2024, the new platform has delivered measurable improvements in marketing effectiveness, customer engagement, and sales volumes. The Company also continues to generally outperform its peers in retail category benchmarks, reflecting the strength of its recent product innovations and the effectiveness of its strategic retail partnerships.

Gross profit in Q1 2025 was $6.2 million, or 50.8% of revenue, compared to gross profit of $6.9 million, or 57.0% of revenue, in Q1 2024. The prior year included temporary items favorable to gross margin. The Company models forward gross margin percentages to continue in the low 50s, supported partly by the transition to in-house production of gummies, followed by topical products over time.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $11.6 million, a 24.2% improvement from $15.3 million in Q1 2024. Stringent expense controls were implemented over the past year and remain a central focus in 2025.

Net loss for the first quarter of 2025 was $6.2 million, or ($0.04) per share basic and diluted, compared to a net loss of $9.7 million, or ($0.06) per share basic and diluted, for the first quarter of 2024.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported negative Adjusted EBITDA1 for the first quarter of 2025 of $2.8 million, a $1.1 million improvement compared to negative Adjusted EBITDA of $3.9 million in the first quarter of 2024.

Balance Sheet and Cash Flow
Net cash used for operations in the first quarter of 2025 was $2.8 million. The Company’s cash and working capital as of March 31, 2025, were $19.4 million and $25.5 million, respectively, compared to $22.6 million and $31.1 million as of December 31, 2024, respectively.

“With cash reserves exceeding $19 million and our anticipated cash flow improvements for this year, we are confident our balance sheet is sufficient to support growth for 2025 and beyond,” said Mrs. Lind.

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s consolidated financial statements and accompanying notes for the three month periods ended March 31, 2025, and 2024, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-Q filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and market leader in hemp extract wellness that includes Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information

Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance, and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions, expected future development, and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume and gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the Company’s ability to increase online traffic and demographic exposure through new products and marketing and omni-channel expansion; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory; launch of products in Whole Foods; continued product placement on various product channels; anticipated development of new products; the outcomes from DeFloria’s clinical trials, including commercial opportunities for Charlotte’s Web.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty, as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars, except share and per share amounts)

March 31,

December 31,

2025 (unaudited)

2024

ASSETS

Current assets:

Cash and cash equivalents

$ 19,357

$ 22,618

Accounts receivable, net

1,531

1,263

Inventories, net

18,916

18,907

Prepaid expenses and other current assets

4,201

4,194

Total current assets

44,005

46,982

Property and equipment, net

25,758

26,337

License and media rights

12,717

13,691

Operating lease right-of-use assets, net

12,404

12,876

Investment in unconsolidated entity

10,700

10,800

SBH purchase option and other derivative assets

970

1,075

Intangible assets, net

1,003

1,049

Other long-term assets

466

632

Total assets

$ 108,023

$ 113,442

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,943

$ 3,426

Accrued and other current liabilities

4,764

5,246

Lease obligations – current

1,844

2,055

License and media rights payable – current

7,937

5,209

Total current liabilities

18,488

15,936

Convertible debenture

44,753

43,631

Lease obligations

13,257

13,652

License and media rights payable

9,227

11,809

Derivative and other long-term liabilities

1,236

1,327

Total liabilities

86,961

86,355

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and
158,009,541 shares issued and outstanding as of March 31, 2025 and December
31, 2024

1

1

Additional paid-in capital

328,842

328,655

Accumulated deficit

(307,781)

(301,569)

Total shareholders’ equity

21,062

27,087

Total liabilities and shareholders’ equity

$ 108,023

$ 113,442

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except share and per share amounts)

Three Months Ended March 31,
(unaudited)

2025

2024

Revenue

$ 12,262

$ 12,124

Cost of goods sold

6,032

5,213

Gross profit

6,230

6,911

Selling, general, and administrative expenses

11,578

15,280

Operating loss

(5,348)

(8,369)

Change in fair value of financial instruments

(126)

(1,860)

Other income (expense), net

(738)

611

Loss before provision for income taxes

$ (6,212)

$ (9,618)

Income tax expense

—

(16)

Net loss

$ (6,212)

$ (9,634)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.04)

$ (0.06)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

Common shares issued upon vesting of restricted share units,
net of withholding

—

—

—

—

—

Share-based compensation

—

—

187

—

187

Net loss

—

(6,212)

(6,212)

Balance—March 31, 2025

158,009,541

$ 1

$ 328,842

$ (307,781)

$ 21,062

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units,
net of withholding

2,895,489

—

(98)

—

(98)

Share-based compensation

—

842

—

842

Net loss

—

(9,634)

(9,634)

Balance—March 31, 2024

157,227,855

$ 1

$ 328,024

$ (281,357)

$ 46,668

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Three Months Ended March 31,
(unaudited)

2025

2024

Cash flows from operating activities:

Net loss

$ (6,212)

$ (9,634)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

2,449

2,493

Change in fair value of financial instruments

126

1,860

Convertible debenture and other accrued interest

868

1,015

Changes in right-of-use assets

473

443

Share-based compensation

187

842

Other

126

(956)

Changes in operating assets and liabilities:

Accounts receivable, net

(394)

98

Inventories, net

19

(1,026)

Prepaid expenses and other current assets

28

150

License and media rights

—

(2,500)

Operating lease obligations

(605)

(551)

Accounts payable, accrued and other liabilities

71

663

Other operating assets and liabilities, net

96

(76)

Net cash used in operating activities

(2,768)

(7,179)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(521)

(2,060)

Proceeds from sale of assets

28

27

Net cash used in investing activities

(493)

(2,033)

Cash flows from financing activities:

Other financing activities

—

(98)

Net cash used in financing activities

—

(98)

Net decrease in cash and cash equivalents

(3,261)

(9,310)

Cash and cash equivalents —beginning of period

22,618

47,820

Cash and cash equivalents —end of period

$ 19,357

$ 38,510

Non-cash activities:

Non-cash purchase of property and equipment and intangible assets

$ (83)

$ (374)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financial measures do not have a standardized meaning prescribed under U.S. GAAP and, therefore, may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

Adjusted EBITDA for the three months ended March 31, 2025, and 2024 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended
March 31,
(unaudited)

U.S. $ Thousands

2025

2024

Net loss

$

(6,212)

$

(9,618)

Depreciation of property and equipment and amortization of intangibles

2,449

2,493

Interest expense

685

487

Income tax expense

16

EBITDA

(3,078)

(6,622)

Share-based compensation

187

842

Mark-to-market financial instruments

126

1,860

Adjusted EBITDA

$

(2,765)

$

(3,920)

SOURCE Charlotte’s Web Holdings, Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/14/c3289.html

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports Year-Over-Year Growth For Q1 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the opening of a new Trulieve-branded dispensary in Lorain, Ohio. Harvest Grows LLC will operate the dispensary under the Trulieve brand through a licensing agreement with the Company.

The new Trulieve-branded dispensary, located at 7420 Oak Point Road, will be open 9 a.m. – 9 p.m., seven days a week, offering walk-in and express pickup service. The dispensary will host a grand opening celebration Friday, May 16, featuring specials and promotional giveaways.

“We are thrilled to open this new dispensary under our licensing agreement with Trulieve,” said Harvest’s Chief Executive Officer, Mark Eiland. “We are proud to be associated with the Trulieve brand and look forward to serving customers at this new location.”

“Harvest Grows is leveraging the Trulieve brand because they know our reputation for quality, value, and exceptional customer service,” said Trulieve’s Chief Executive Officer Kim Rivers. “We wish them all the best in operating their new dispensary.”

The new dispensary, located at 7420 Oak Point Road, will be open 9 a.m. – 9 p.m., seven days a week, offering walk-in and express pickup service. Trulieve operates owned dispensaries at the following locations in Ohio:

4370 Tonawanda Trail, Beavercreek

2950 N. High Street, Columbus

601 S. High Street, Columbus

8295 Sancus Blvd, Westerville

3674 Maple Avenue, Zanesville

Trulieve dispensaries offer customers a wide assortment of cannabis products featuring popular brands and accessible form factors including capsules, edibles, flower, tinctures and topicals. For more information on store activations and locations in Ohio, please visit https://www.trulieve.com/dispensaries/ohio.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck, APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-branded-dispensary-to-open-in-lorain-ohio-302454592.html

SOURCE Trulieve Cannabis Corp.

The post Trulieve Cannabis Corp. (TCNNF) Dispensary to Open in Lorain, Ohio appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry has faced significant challenges in recent years, leading to a downturn in marijuana stock prices. Despite the current market conditions, there may be a strategic opportunity for investors. With how low the sector has fallen, this risk vs reward opportunity could be profitable. The cannabis sector needs a big momentum change and an impactful catalyst to do so.

This is where many feel the passing of federal reform will be the dominant shift for most marijuana stocks. Market corrections are often where real value is found. Cannabis stocks are currently trading at historically low price-to-sales and price-to-book ratios. What this means is investors can find top marijuana stocks to buy at steal valuations. Now, most of the time it is a waiting game as to when a volatile pop will occur, so long-term planning is what’s occurring.

In short, while the cannabis sector has faced headwinds, current lows may not reflect the long-term potential of the industry. For investors willing to be patient, the current downtrend could be a rare chance to buy low before the next wave of growth begins. Just make sure you do your research and develop a trading strategy that works for you. Below are several marijuana stocks to watch today.

Marijuana Stocks For Your 2025 Portfolio

1. FLUENT Corp. (OTC:CNTMF)
2. Glass House Brands Inc.(OTC:GLASF)
3. Ascend Wellness Holdings, Inc. (OTC:AAWH)

FLUENT Corp.

FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

In recent news, the company released New York Minute, a bold new addition to its MOODS vaporizer portfolio. The new offering will be available in two convenient All-in-One device formats: a 1g Mini and a 0.5g Dash, catering to consumers who seek portability, performance,e and taste.

Words From The CEO

“New York sets the tone for culture, innovation, and lifestyle—and we wanted to create a vape product that connects with that essence,” said Robert Beasley, CEO of FLUENT.”

Glass House Brands Inc.

Glass House Brands Inc. operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

The company has recently announced in partnership with LEEF Brands Inc. This Management Services Agreement Glass House will manage operations of LEEF’s Palm Desert, California, dispensary, “The Leaf El Paseo,” on behalf of LEEF. Glass House will assume daily management responsibilities of The Leaf El Paseo.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.

In recent updates, the company has reported its Q1 2025 earnings.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

Financial Highlights
Revenue:

• Total net revenue declined 5.9% quarter-over-quarter to $128.0 million.
• Retail revenue decreased 6.6% quarter-over-quarter to $84.4 million.
• Wholesale revenue decreased 4.4% quarter-over-quarter to $43.6 million.
  Net Loss:
• Net loss of $19.3 million in Q1 2025 compared to net loss of $16.8 million in Q4 2024.

The post These Cannabis Stocks Could Pay Off Big In The Future appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..